SBFM
Next report

Nov 12 2026in 45 days

EPS estimate

($0.17)

Revenue estimate

$10M

EPS beats

3 of last 11

EPS surprise

2023: -566.7%2024: -1566.7%2024: -150.0%2024: -1556.7%2024: 99.8%2025: -10200.0%2025: -254.5%2025: -46.2%2026: -11.1%2026: 0.0%2026: 4.2%
Nov 13 2023Aug 13 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 13 2026($1.20)($1.15)+4.2%$9M$9M+6.9%
May 13 2026($2.50)($2.50)+0.0%$8M$8M+0.0%
Apr 3 2026($2.70)($3.00)-11.1%$10M$9M-14.0%
Nov 13 2025($1.30)($1.90)-46.2%$11M$9M-15.2%
Aug 12 2025($1.10)($3.90)-254.5%$11M$9M-16.0%
May 15 2025—($4.40)——$9M—
Mar 31 2025$0.10($10.10)-10200.0%$13M$10M-23.2%
Nov 5 2024($5350.00)($9.40)+99.8%$12M$8M-28.5%
Aug 19 2024($0.06)($0.99)-1556.7%$9M$9M+3.4%
May 20 2024($1.60)($4.00)-150.0%$7M$8M+7.7%
Mar 28 2024($0.60)($10.00)-1566.7%$6M$8M+25.9%
Nov 13 2023($1.20)($8.00)-566.7%$6M$6M-0.7%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+25.70%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$36M$45M
Low$36M$45M
High$36M$45M
EBITDA Avg$-246,743$608,234
Low$-246,743$608,234
High$-246,743$608,234
EBIT Avg$-761,940$-117,590
Low$-761,940$-117,590
High$-761,940$-117,590
Net Income Avg$-810,634$-166,284
Low$-810,634$-166,284
High$-810,634$-166,284
EPS Avg$-1.95$-0.40
Low$-1.95$-0.40
High$-1.95$-0.40
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026
Revenue Avg$10M$10M
Low$10M$10M
High$10M$10M
EBITDA Avg$-141,300$-292,602
Low$-141,300$-292,602
High$-141,300$-292,602
EBIT Avg$-232,105$-395,944
Low$-232,105$-395,944
High$-232,105$-395,944
Net Income Avg$-232,105$-395,944
Low$-232,105$-395,944
High$-232,105$-395,944
EPS Avg$-0.17$-0.29
Low$-0.17$-0.29
High$-0.17$-0.29
Analysts (Rev / EPS)1 / 11 / 1

Earnings Call Transcripts

No earnings transcripts available for SBFM

Transcripts may not be available for all companies

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.